cgp 12177 and vilanterol

cgp 12177 has been researched along with vilanterol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett, VJ; Emmons, AJ; Ford, AJ; Knowles, RG; Morrison, VS; Slack, RJ; Sturton, RG	1

Other Studies

1 other study(ies) available for cgp 12177 and vilanterol

Article	Year
In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:1 Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Albuterol; Animals; Benzyl Alcohols; Binding, Competitive; Cell Membrane; Cells, Cultured; Chlorobenzenes; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Data Interpretation, Statistical; Fluorescence Polarization; Guinea Pigs; Humans; Kinetics; Propanolamines; Pulmonary Disease, Chronic Obstructive; Radioligand Assay; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate	2013

Article

Year

In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.

The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:1

Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Albuterol; Animals; Benzyl Alcohols; Binding, Competitive; Cell Membrane; Cells, Cultured; Chlorobenzenes; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Data Interpretation, Statistical; Fluorescence Polarization; Guinea Pigs; Humans; Kinetics; Propanolamines; Pulmonary Disease, Chronic Obstructive; Radioligand Assay; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate

2013